DOJ Subpoenas for Transgender Care Face Court Challenge, Key Ruling Looms
The legal battle over the Trump administration’s efforts to access medical records related to gender-affirming care for young people is entering a critical phase, with oral arguments scheduled Friday in a Ninth Circuit court in Seattle. The case, stemming from a subpoena issued to the telehealth company QueerDoc, could set a precedent for how the Department of Justice pursues similar cases and potentially influence whether the dispute reaches the Supreme Court. This development arrives amidst ongoing scrutiny of Attorney General Pam Bondi’s role in directing a federal investigation into these medical practices, a move critics allege is politically motivated.
Last spring, Attorney General Bondi issued a memo directing federal law enforcement to prioritize investigations into pediatric gender-affirming care, characterizing “gender ideology” as a harmful influence on a generation of children. Following this, the Justice Department issued over 20 subpoenas to clinics and doctors providing such care, demanding extensive patient data including names, Social Security numbers, and diagnoses. While several of these subpoenas have been blocked or limited by federal judges, the DOJ is appealing five of those rulings, with the QueerDoc case leading the way.
The DOJ’s Strategy and Judicial Pushback
The Justice Department asserts We see investigating potential false or misleading claims related to hormones and puberty blockers, and whether fraudulent diagnostic codes are being used. However, multiple federal district courts have expressed strong skepticism about the DOJ’s motives. Judges have described the department’s actions as driven by “bad faith,” motivated by a “policy agenda,” and exceeding the authority granted by Congress. U.S. District Judge Jamal Whitehead, in October, explicitly stated that “no clearer evidence of improper purpose could exist than the Government’s own repeated declarations that it seeks to end the very practice it claims to be merely investigating,” referencing President Trump’s executive order on gender-affirming care and a now-removed statement on the White House website outlining his commitment to halting such care.
Chief U.S. District Judge Cathy Bissoon went even further, describing the government’s pursuit of records from the University of Pittsburgh Medical Center as smelling not of a “whiff” but “closer to a stench.” She rejected an amended subpoena even after the government offered to request anonymized records.
A DOJ spokesperson, when asked for comment on the district court rulings and appeals, stated the department “will use every legal and law enforcement tool available to protect innocent children from being mutilated under the guise of ‘care.’”
QueerDoc and the Appeal Process
The subpoena served to QueerDoc, a telehealth company, wasn’t delivered with the formality often depicted in television dramas. Instead, founder Crystal Beal received a frantic message from her accountant forwarding an email from the government while she was actively seeing patients. Beal, anticipating such a move given the Trump administration’s stated opposition to adolescent gender-affirming care, still found the experience “scary.”
The subpoena requested highly sensitive patient information, raising fears within the transgender community that the administration could use the data to target individuals. The DOJ argues it’s seeking to identify any misuse of medical billing codes or unsubstantiated claims about the treatments. However, the legal argument hinges on whether prescribing medications “off-label” – meaning for a purpose not specifically approved by the FDA – is inherently illegal, a point legal experts contest, as off-label prescribing is a common and accepted medical practice.
The DOJ prioritized the QueerDoc appeal, a decision that has raised eyebrows among legal observers. Adrien Leavitt, an ACLU attorney working with QueerDoc, suspects the department deliberately chose to first challenge a smaller, independent clinic lacking extensive in-house legal resources, rather than larger hospital systems. “I think that there’s something profound about the fact that the government sought expedited review and was granted expedited review in this case, but didn’t do so in other cases,” Leavitt said.
What’s at Stake: Precedent and Potential Circuit Split
The Ninth Circuit’s ruling in the QueerDoc case will be binding only within that circuit. However, it will serve as a crucial precedent for other courts grappling with similar issues. A significant divergence in rulings across different circuits – a “circuit split” – could increase the likelihood of the Supreme Court taking up the case.
Beyond the legal implications, the outcome of these appeals could influence the willingness of clinics to continue providing gender-affirming care. Dozens of hospitals and health systems have already limited or halted such services, citing concerns about potential legal challenges and the risk of losing federal funding. The possibility of proposed federal rules barring Medicare and Medicaid funding for institutions offering pediatric gender-affirming care, coupled with investigations from the Department of Health and Human Services, has further contributed to this trend.
Crystal Beal of QueerDoc remains steadfast in her commitment to providing care. “I seek to be the adult I didn’t have in my own life, for the younger people in my community,” she said. “Here’s the role of an elder in a community.”
The coming months will be pivotal in determining the future of gender-affirming care for young people in the United States, as the courts weigh the legal arguments and the broader implications for patient access and medical freedom. The Friday arguments in Seattle represent a key moment in this unfolding legal and political battle.